P4A To Discuss Early Access Strategy Insights In New Webinar

Leading specialist market access consultancy Partners4Access (P4A) is to host a free webinar that will share insights on key considerations for pharma/biotech manufacturers on early access program strategy and implementation. The webinar titled ` Early Access Programs in Europe: ‘A Friend or a Foe’ will be conducted by educational webinars provider Xtalks and will be…

Read more

P4A shares insights on gene therapy access at WODC US 2020

Leading specialist market access consultancy Partners4Access (P4A) has announced it will share insights on gene therapy access for rare diseases at the biotech industry conference World Orphan Drug Congress (WODC) US. Due to COVID-19 travel restrictions, the event is being held virtually between August 24-27, 2020. P4A are gold sponsors and are also exhibiting at…

Read more

P4A sponsors World Orphan Drug Congress Europe 2019

Leading specialist market access consultancy Partners4Access has announced their gold sponsorship of the biotech industry conference World Orphan Drug Congress (WODC) Europe. The event will take place at Hotel Sofia, Barcelona between November 13-14, 2019. P4A’s Sophie Schmitz, managing partner; Akshay Kumar, partner; Aparna Krishnan, director and Nicola Allen, associate director will be attending the…

Read more

Partners4Access expands top leadership with new appointment

Partners4Access has announced the appointment of Akshay Kumar as Partner to lead its rapidly expanding global strategic market access team. Akshay brings a wealth of market access experience built over a decade from previous roles with Huron as Senior Director – Orphan Drugs, Cell & Gene Therapy commercialization, and at ZS Associates as European Market…

Read more

Partners4Access sponsors World Orphan Drug Congress USA 2019

Partners4Access has announced their gold sponsorship of the biotech industry conference World Orphan Drug Congress (WODC) USA. The event will take place at The Gaylord National Harbor Hotel in Oxon Hill, Maryland between April 10-12, 2019. The P4A team will be involved in three main segments of WODC: Sophie Schmitz, Managing Partner will be moderating…

Read more

P4A to present Cell & Gene Therapy insights at WODC 2018

Partners4Access, a leading market access consultancy specializing in orphan drugs, cell and gene therapy today announced its participation at the World Orphan Drug Congress, an industry conference that brings together rare disease stakeholders under a common platform. The three-day event is being held between November 6-8, 2018 in Barcelona, Spain. P4A’s Sophie Schmitz, Managing Partner…

Read more

Partners4access to attend BIA’s networking event

As part of its business expansion activities, Partners4Access’ Sophie Schmitz will be attending industry group, BioIndustry Association (BIA)’s Summer Networking Reception on Thursday, July 12. The event will take place at IET Savoy Place, London. P4A became a member of BIA in June this year. BIA represents several stakeholders within the biosciences area from small…

Read more

Partners4Access joins biotech trade association, BIA

Partners4Access has announced its membership of the UK’s leading biotechnology focused industry group, BioIndustry Association (BIA). BIA represents several stakeholders within the biosciences area from small clinical stage biotechs, large pharma corporations, academics and service providers to the biotech industry. Their members account for majority of biotech drugs currently in clinical development. BIA is a…

Read more